19-9186442-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_175883.4(OR7D2):c.661A>T(p.Ile221Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000273 in 1,613,902 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
OR7D2
NM_175883.4 missense
NM_175883.4 missense
Scores
3
4
12
Clinical Significance
Conservation
PhyloP100: 6.00
Genes affected
OR7D2 (HGNC:8378): (olfactory receptor family 7 subfamily D member 2) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR7D2 | NM_175883.4 | c.661A>T | p.Ile221Phe | missense_variant | 3/3 | ENST00000641288.2 | |
OR7D2 | NM_001386112.1 | c.661A>T | p.Ile221Phe | missense_variant | 2/2 | ||
OR7D2 | XM_047438317.1 | c.661A>T | p.Ile221Phe | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR7D2 | ENST00000641288.2 | c.661A>T | p.Ile221Phe | missense_variant | 3/3 | NM_175883.4 | P1 | ||
OR7D2 | ENST00000344248.4 | c.661A>T | p.Ile221Phe | missense_variant | 1/1 | P1 | |||
OR7D2 | ENST00000642043.1 | c.661A>T | p.Ile221Phe | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152010Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
152010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251458Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135906
GnomAD3 exomes
AF:
AC:
38
AN:
251458
Hom.:
AF XY:
AC XY:
12
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461892Hom.: 0 Cov.: 34 AF XY: 0.0000193 AC XY: 14AN XY: 727248
GnomAD4 exome
AF:
AC:
42
AN:
1461892
Hom.:
Cov.:
34
AF XY:
AC XY:
14
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152010Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74236
GnomAD4 genome
AF:
AC:
2
AN:
152010
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
20
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2023 | The c.661A>T (p.I221F) alteration is located in exon 1 (coding exon 1) of the OR7D2 gene. This alteration results from a A to T substitution at nucleotide position 661, causing the isoleucine (I) at amino acid position 221 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;.;T
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;H;H
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Uncertain
.;.;D
REVEL
Benign
Sift
Pathogenic
.;.;D
Sift4G
Pathogenic
.;.;D
Polyphen
D;D;D
Vest4
0.59
MutPred
Loss of MoRF binding (P = 0.1168);Loss of MoRF binding (P = 0.1168);Loss of MoRF binding (P = 0.1168);
MVP
0.38
MPC
0.50
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at